- Home
- NBTX vs PEBK Comparison
NBTX vs PEBK Comparison
Compare NBTX & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- PEBK
- Stock Information
- Founded
- NBTX 2003
- PEBK 1912
- Country
- NBTX France
- PEBK United States
- Employees
- NBTX N/A
- PEBK N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- PEBK Major Banks
- Sector
- NBTX Health Care
- PEBK Finance
- Exchange
- NBTX Nasdaq
- PEBK Nasdaq
- Market Cap
- NBTX 201.9M
- PEBK 169.6M
- IPO Year
- NBTX 2020
- PEBK N/A
- Fundamental
- Price
- NBTX $3.26
- PEBK $31.20
- Analyst Decision
- NBTX Strong Buy
- PEBK
- Analyst Count
- NBTX 1
- PEBK 0
- Target Price
- NBTX $12.00
- PEBK N/A
- AVG Volume (30 Days)
- NBTX 64.6K
- PEBK 31.0K
- Earning Date
- NBTX 12-31-2024
- PEBK 01-21-2025
- Dividend Yield
- NBTX N/A
- PEBK 2.40%
- EPS Growth
- NBTX N/A
- PEBK 1.99
- EPS
- NBTX N/A
- PEBK 2.95
- Revenue
- NBTX $45,220,186.00
- PEBK $79,995,000.00
- Revenue This Year
- NBTX N/A
- PEBK N/A
- Revenue Next Year
- NBTX N/A
- PEBK N/A
- P/E Ratio
- NBTX N/A
- PEBK $10.75
- Revenue Growth
- NBTX 526.17
- PEBK 3.47
- 52 Week Low
- NBTX $2.76
- PEBK $23.74
- 52 Week High
- NBTX $8.96
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- NBTX 42.55
- PEBK 60.99
- Support Level
- NBTX $3.18
- PEBK $30.75
- Resistance Level
- NBTX $3.69
- PEBK $32.65
- Average True Range (ATR)
- NBTX 0.27
- PEBK 0.78
- MACD
- NBTX 0.07
- PEBK -0.20
- Stochastic Oscillator
- NBTX 56.45
- PEBK 41.41
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.